Does SIMVASTATIN Cause Therapeutic product effect incomplete? 204 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 204 reports of Therapeutic product effect incomplete have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.8% of all adverse event reports for SIMVASTATIN.
204
Reports of Therapeutic product effect incomplete with SIMVASTATIN
0.8%
of all SIMVASTATIN reports
1
Deaths
148
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From SIMVASTATIN?
Of the 204 reports, 1 (0.5%) resulted in death, 148 (72.5%) required hospitalization, and 8 (3.9%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 204 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which SIMVASTATIN Alternatives Have Lower Therapeutic product effect incomplete Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS